Novartis in Egypt
Novartis was created in 1996 through a merger of Ciba-Geigy and Sandoz. Novartis and its predecessor companies trace roots back more than 250 years, with a rich history of developing innovative products.
Our strategy is to build a leading, focused medicines company powered by advanced therapy platforms and data science.
Diversity and Inclusion
We want to build a diverse and inclusive workplace where every one of us can be our best and true selves, so that together we can discover more, reach underserved communities and reimagine medicine.
People and Culture
We must fundamentally reimagine the way we work and create a culture that brings out the best in our people to fulfill our purpose of reimagining medicine to improve and extend people’s lives.
Our Innovative Medicines business is made up of two separate commercial organizations, Innovative Medicines International and Innovative Medicines US.
A list of the treatments we currently offer via our Innovative Medicines Division.
Country Leadership Team
We reimagine medicine to improve and extend people’s lives. We use innovative science and technology to address some of society’s most challenging healthcare issues.
Whether you're a customer, job seeker, health or media professional or an investor, find the best way to contact us.